ESPR
Esperion Therapeutics, Inc.$1.90-0.01 (-0.26%)Prev Close$1.91·MCap$397.1M·P/E—·Vol4.67M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
17
$511.0K
◆
Net Activity
Net Seller
$511.0K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Esperion Therapeutics, Inc. (ESPR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $511.0K. The most recent insider transaction was by Halladay Benjamin (officer: Chief Financial Officer), who sold $17.4K worth of shares on Mar 18, 2026. Esperion Therapeutics, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $397.1M.
ESPR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Halladay Benjamin | officer: Chief Financial Officer | Sell | 6,424 | $2.70 | $17.4K | 713,602 |
| Mar 18, 2026 | Koenig Sheldon L. | director, officer: President and CEO | Sell | 25,578 | $2.72 | $69.5K | 2,172,699 |
| Mar 18, 2026 | Looker Benjamin | officer: Chief Legal Officer | Sell | 5,708 | $2.70 | $15.4K | 679,348 |
| Jan 21, 2026 | Looker Benjamin | officer: General Counsel | Sell | 1,689 | $2.88 | $4.9K | 384,216 |
| Jan 20, 2026 | Looker Benjamin | General Counsel | Sell | 1,689 | $2.88 | $4.9K | 384,216 |
| Dec 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 48,244 | $3.67 | $177.2K | 0 |
| Dec 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,517 | $3.67 | $23.9K | 0 |
| Dec 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,337 | $3.67 | $26.9K | 467,525 |
| Oct 17, 2025 | Looker Benjamin | General Counsel | Sell | 1,248 | $2.62 | $3.3K | 0 |
| Sep 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 28,427 | $2.79 | $79.3K | 0 |
| Sep 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,046 | $2.81 | $19.8K | 474,862 |
| Sep 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,267 | $2.80 | $17.6K | 393,670 |
| Jul 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.12 | $12.27 | 0 |
| Jul 17, 2025 | Looker Benjamin | General Counsel | Sell | 1,304 | $1.13 | $1.5K | 0 |
| Jun 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,229 | $1.15 | $8.3K | 0 |
| Jun 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 30,474 | $1.11 | $33.8K | 0 |
| Jun 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,422 | $1.15 | $7.4K | 0 |
| Apr 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 8 | $0.96 | $7.71 | 0 |
| Apr 17, 2025 | Warren Eric | Chief Commercial Officer | Sell | 108 | $0.98 | $105.62 | 0 |
| Mar 18, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 3,535 | $1.48 | $5.2K | 0 |
| Mar 18, 2025 | Koenig Sheldon L. | President and CEO | Sell | 13,047 | $1.50 | $19.6K | 0 |
| Mar 18, 2025 | Warren Eric | Chief Commercial Officer | Sell | 2,433 | $1.49 | $3.6K | 0 |
| Feb 19, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.86 | $20.46 | 240,671 |
| Feb 19, 2025 | Warren Eric | Chief Commercial Officer | Sell | 239 | $1.87 | $446.45 | 159,759 |
| Jan 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 9 | $2.27 | $20.39 | 240,682 |
| Jan 17, 2025 | Warren Eric | Chief Commercial Officer | Sell | 123 | $2.26 | $277.98 | 159,998 |
| Dec 17, 2024 | Halladay Benjamin | Chief Financial Officer | Sell | 3,245 | $2.42 | $7.9K | 240,691 |
| Dec 17, 2024 | Koenig Sheldon L. | President and CEO | Sell | 12,447 | $2.47 | $30.7K | 739,819 |
| Dec 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,234 | $2.43 | $5.4K | 160,121 |
| Nov 19, 2024 | Warren Eric | Chief Commercial Officer | Sell | 197 | $2.16 | $426.50 | 162,355 |
| Oct 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 107 | $2.12 | $226.73 | 162,552 |
| Sep 17, 2024 | Koenig Sheldon L. | President and CEO | Sell | 14,550 | $1.80 | $26.1K | 752,266 |
| Sep 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,608 | $1.78 | $4.7K | 162,659 |
| Aug 19, 2024 | Warren Eric | Chief Commercial Officer | Sell | 211 | $1.95 | $410.61 | 165,267 |
| Jul 17, 2024 | Foody Joanne M. | Chief Medical Officer | Sell | 917 | $2.60 | $2.4K | 272,862 |
| Jul 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 108 | $2.59 | $279.40 | 165,478 |
| Jun 18, 2024 | Foody Joanne M. | Chief Medical Officer | Sell | 3,285 | $2.87 | $9.4K | 273,779 |
| Jun 18, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,540 | $2.86 | $7.3K | 165,586 |
| May 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 192 | $2.48 | $476.74 | 168,126 |
| Sep 20, 2023 | Warren Eric | Chief Commercial Officer | Sell | 742 | $1.25 | $923.79 | 68,318 |
| Aug 18, 2023 | Warren Eric | Chief Commercial Officer | Sell | 243 | $1.41 | $343.60 | 69,060 |
| Jul 19, 2023 | Warren Eric | Chief Commercial Officer | Sell | 106 | $1.59 | $168.01 | 69,303 |
| Jun 21, 2023 | Warren Eric | Chief Commercial Officer | Sell | 603 | $1.48 | $894.25 | 69,409 |
| May 17, 2023 | Warren Eric | Chief Commercial Officer | Sell | 219 | $1.62 | $355.66 | 70,012 |
| May 10, 2023 | CARROLL J MARTIN | Director | Buy | 31,500 | $1.55 | $48.8K | 36,500+630% |
| May 10, 2023 | ROCAMBOLI STEPHEN | Director | Buy | 8,111 | $1.50 | $12.1K | 8,111 |
| May 9, 2023 | Koenig Sheldon L. | President and CEO | Buy | 20,000 | $1.26 | $25.2K | 312,816 |
| Apr 19, 2023 | Foody Joanne M. | Chief Medical Officer | Sell | 938 | $1.27 | $1.2K | 127,064 |
| Apr 19, 2023 | Looker Benjamin | General Counsel | Sell | 1,290 | $1.27 | $1.6K | 83,663 |
| Apr 19, 2023 | Warren Eric | Chief Commercial Officer | Sell | 115 | $1.28 | $146.97 | 70,231 |
Showing 1–50 of 75
1 / 2
ESPR Insider Buying Activity
The following table shows recent insider purchases of Esperion Therapeutics, Inc. (ESPR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 10, 2023 | CARROLL J MARTIN | Director | Buy | 31,500 | $1.55 | $48.8K | 36,500+630% |
| May 10, 2023 | ROCAMBOLI STEPHEN | Director | Buy | 8,111 | $1.50 | $12.1K | 8,111 |
| May 9, 2023 | Koenig Sheldon L. | President and CEO | Buy | 20,000 | $1.26 | $25.2K | 312,816 |
ESPR Insider Selling Activity
The following table shows recent insider sales of Esperion Therapeutics, Inc. (ESPR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Halladay Benjamin | officer: Chief Financial Officer | Sell | 6,424 | $2.70 | $17.4K | 713,602 |
| Mar 18, 2026 | Koenig Sheldon L. | director, officer: President and CEO | Sell | 25,578 | $2.72 | $69.5K | 2,172,699 |
| Mar 18, 2026 | Looker Benjamin | officer: Chief Legal Officer | Sell | 5,708 | $2.70 | $15.4K | 679,348 |
| Jan 21, 2026 | Looker Benjamin | officer: General Counsel | Sell | 1,689 | $2.88 | $4.9K | 384,216 |
| Jan 20, 2026 | Looker Benjamin | General Counsel | Sell | 1,689 | $2.88 | $4.9K | 384,216 |
| Dec 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 48,244 | $3.67 | $177.2K | 0 |
| Dec 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,517 | $3.67 | $23.9K | 0 |
| Dec 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,337 | $3.67 | $26.9K | 467,525 |
| Oct 17, 2025 | Looker Benjamin | General Counsel | Sell | 1,248 | $2.62 | $3.3K | 0 |
| Sep 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 28,427 | $2.79 | $79.3K | 0 |
| Sep 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,046 | $2.81 | $19.8K | 474,862 |
| Sep 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,267 | $2.80 | $17.6K | 393,670 |
| Jul 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.12 | $12.27 | 0 |
| Jul 17, 2025 | Looker Benjamin | General Counsel | Sell | 1,304 | $1.13 | $1.5K | 0 |
| Jun 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,229 | $1.15 | $8.3K | 0 |
| Jun 17, 2025 | Koenig Sheldon L. | President and CEO | Sell | 30,474 | $1.11 | $33.8K | 0 |
| Jun 17, 2025 | Looker Benjamin | General Counsel | Sell | 6,422 | $1.15 | $7.4K | 0 |
| Apr 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 8 | $0.96 | $7.71 | 0 |
| Apr 17, 2025 | Warren Eric | Chief Commercial Officer | Sell | 108 | $0.98 | $105.62 | 0 |
| Mar 18, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 3,535 | $1.48 | $5.2K | 0 |
| Mar 18, 2025 | Koenig Sheldon L. | President and CEO | Sell | 13,047 | $1.50 | $19.6K | 0 |
| Mar 18, 2025 | Warren Eric | Chief Commercial Officer | Sell | 2,433 | $1.49 | $3.6K | 0 |
| Feb 19, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.86 | $20.46 | 240,671 |
| Feb 19, 2025 | Warren Eric | Chief Commercial Officer | Sell | 239 | $1.87 | $446.45 | 159,759 |
| Jan 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 9 | $2.27 | $20.39 | 240,682 |
| Jan 17, 2025 | Warren Eric | Chief Commercial Officer | Sell | 123 | $2.26 | $277.98 | 159,998 |
| Dec 17, 2024 | Halladay Benjamin | Chief Financial Officer | Sell | 3,245 | $2.42 | $7.9K | 240,691 |
| Dec 17, 2024 | Koenig Sheldon L. | President and CEO | Sell | 12,447 | $2.47 | $30.7K | 739,819 |
| Dec 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,234 | $2.43 | $5.4K | 160,121 |
| Nov 19, 2024 | Warren Eric | Chief Commercial Officer | Sell | 197 | $2.16 | $426.50 | 162,355 |
| Oct 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 107 | $2.12 | $226.73 | 162,552 |
| Sep 17, 2024 | Koenig Sheldon L. | President and CEO | Sell | 14,550 | $1.80 | $26.1K | 752,266 |
| Sep 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,608 | $1.78 | $4.7K | 162,659 |
| Aug 19, 2024 | Warren Eric | Chief Commercial Officer | Sell | 211 | $1.95 | $410.61 | 165,267 |
| Jul 17, 2024 | Foody Joanne M. | Chief Medical Officer | Sell | 917 | $2.60 | $2.4K | 272,862 |
| Jul 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 108 | $2.59 | $279.40 | 165,478 |
| Jun 18, 2024 | Foody Joanne M. | Chief Medical Officer | Sell | 3,285 | $2.87 | $9.4K | 273,779 |
| Jun 18, 2024 | Warren Eric | Chief Commercial Officer | Sell | 2,540 | $2.86 | $7.3K | 165,586 |
| May 17, 2024 | Warren Eric | Chief Commercial Officer | Sell | 192 | $2.48 | $476.74 | 168,126 |
| Sep 20, 2023 | Warren Eric | Chief Commercial Officer | Sell | 742 | $1.25 | $923.79 | 68,318 |
| Aug 18, 2023 | Warren Eric | Chief Commercial Officer | Sell | 243 | $1.41 | $343.60 | 69,060 |
| Jul 19, 2023 | Warren Eric | Chief Commercial Officer | Sell | 106 | $1.59 | $168.01 | 69,303 |
| Jun 21, 2023 | Warren Eric | Chief Commercial Officer | Sell | 603 | $1.48 | $894.25 | 69,409 |
| May 17, 2023 | Warren Eric | Chief Commercial Officer | Sell | 219 | $1.62 | $355.66 | 70,012 |
| Apr 19, 2023 | Foody Joanne M. | Chief Medical Officer | Sell | 938 | $1.27 | $1.2K | 127,064 |
| Apr 19, 2023 | Looker Benjamin | General Counsel | Sell | 1,290 | $1.27 | $1.6K | 83,663 |
| Apr 19, 2023 | Warren Eric | Chief Commercial Officer | Sell | 115 | $1.28 | $146.97 | 70,231 |
ESPR Insiders
Similar Stocks to ESPR
ZTS
Zoetis Inc.
$116.65-1.17%
$49.24B
VTRS
Viatris Inc.
$14.76-0.27%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$128.16+0.10%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.23-0.23%
$4.15B
SUPN
Supernus Pharmaceuticals, Inc.
$48.70-1.54%
$2.87B
PAHC
Phibro Animal Health Corporation
$53.65-4.44%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.91-0.87%
$1.79B
PRGO
Perrigo Company plc
$11.53+0.30%
$1.61B